To cite this paper use one of the standards below:
Background: Approximately 10% of live births worldwide are preterm, interrupting critical neurodevelopmental processes that normally occur during the last trimester. HES1, a transcriptional regulator of neural progenitor cell maintenance and differentiation, may undergo aberrant DNA methylation in preterm infants, potentially marking early neurodevelopmental perturbations.
Objective: This study aimed to profile HES1 promoter methylation over the first three months of life in preterm and term newborns and to assess its potential as an epigenetic biomarker for early neurodevelopmental alterations.
Methods: In a prospective longitudinal design, 49 term and 46 preterm infants were enrolled at the Maternity School of UFRJ. Cord blood was sampled at birth (D0) for both groups; peripheral blood was collected at day 5 (D5) for all infants and additionally at days 30 (D30) and 90 (D90) for preterm infants. After DNA extraction and bisulfite conversion, nine CpG sites within the HES1 promoter region (Chr3:193,849,141–193,849,361) were amplified by PCR and quantified via pyrosequencing on a PyroMark Q48. Methylation levels were compared between groups at each time point using Mann–Whitney U tests, and temporal trends in preterm infants were evaluated with generalized linear models.
Results: At D0, preterm infants exhibited significantly lower methylation across all nine CpG sites compared to term controls (all p < 0.05). By D5, methylation in preterm infants partially converged toward term levels, although differences remained at several sites. Persistent hypomethylation at D30 and D90 (mean Δ methylation ≥ 5% at multiple CpGs) indicated enduring epigenetic divergence.
Conclusions: HES1 promoter hypomethylation is evident immediately after preterm birth and persists through three months of age. These methylation dynamics may serve as a potential early biomarker of neurodevelopmental alterations, highlighting a critical window for epigenetic intervention in the NICU.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper